NCT02687958 - Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions

Neuroendocrine Carcinoma

Interventions

DRUG

Everolimus

Maintenance therapy

Trial Locations (5)

Istituto Europeo di Oncologia, Milan

"Azienda Ospedaliera Spedali Civili di Brescia", Brescia

S.C. Oncologia - Policlinico, Modena

Azienda Ospedaliera Universitaria Careggi, Florence

U.O. Oncologia Medica 1 - AOU Pisana, Pisa